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S UMMA R Y
S E T T I NG : Zambian and South African TB and HIV
Reduction (ZAMSTAR) cluster-randomised trial (CRT)
communities, 2006–2009.
OB J E C T I V E S : To develop TB stigma items, and evalu-
ate changes in them in response to a household
intervention aimed at reducing TB transmission and
prevalence but not tailored to reduce stigma.
DE S I GN : TB stigma was measured at baseline and 18
months later among 1826 recently diagnosed TB
patients and 1235 adult members of their households
across 24 communities; 12 of 24 communities were
randomised to receive the household intervention. We
estimated the impact of the household intervention on
TB stigma using standard CRT analytical methods.
R E SU LT S : Among household members, prevalence of
blame and belief in transmission myths fell in both study
arms over time: adjusted prevalence ratios (aPRs)
comparing the household intervention with the non-
household intervention arm were respectively 0.61
(95%CI 0.26–1.44) and 0.77 (95%CI 0.48–1.25) at
18-month follow-up. Among TB patients, at baseline a
low percentage experienced social exclusion and poor
treatment by health staff and a relatively high percentage
reported ‘being made fun of’, with little change over
time. Disclosure of TB status increased over time in both
study arms. Internalised stigma was less prevalent in the
household arm at both baseline and follow-up, with an
aPR of 0.85 (95%CI 0.41–1.76). Variability in stigma
levels between countries and across communities was
large.
CONC LU S I ON : Robust TB stigma items were devel-
oped. TB stigma was not significantly reduced by the
household intervention, although confidence intervals
for estimated intervention effects were wide. We suggest
that stigma-specific interventions are required to effec-
tively address TB stigma.
K E Y WORD S : TB; stigma; CRT; variability
ONE PUBLIC HEALTH APPROACH to reducing
disease-related stigma is to improve disease manage-
ment, which may in turn have the downstream effect
of reducing stigma. For example, it has been argued
that human immunodeficiency virus (HIV) stigma
will be reduced by making HIV treatment widely
available.1 Through secondary analysis of data from
a cluster-randomised trial (CRT) in Zambia and
South Africa, this paper asks whether an intervention
that was delivered to the households of tuberculosis
(TB) patients, aimed at improving patient outcomes
and ultimately at reducing TB transmission and
prevalence in the wider community,2 also succeeded
in reducing TB stigma.
Stigmatisation of TB is widely reported in the
literature.3–6 Key domains of TB stigma include
unnecessary fears of transmission, shame, experience
of social exclusion, experience of being made fun of,
experience of health-setting stigma, internal stigma
and disclosure.7–9 Despite wide recognition of the
issue of TB stigma, there has been relatively little
research on the development and application of TB
stigma items, or on using such items to evaluate the
effect of TB interventions on TB stigma. We used data
from a large cohort of TB patient households in
Zambia and South Africa to develop indicators for
various TB stigma domains, and to evaluate whether
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TB stigma was reduced by a household-level TB
intervention.
METHODS
The Zambian and South African TB and HIV Reduction
Trial Design
The objective of a CRT (Zambian and South African
TB and HIV Reduction study [ZAMSTAR]), carried
out from 2004 to 2011 in 24 urban communities (16
in Zambia, 8 in Western Cape, South Africa), was to
establish whether it was possible to reduce TB
prevalence and incidence at community level using
interventions beyond the health services.2 Figure 1
summarises the key timelines from the perspective of
this analysis in the design, flow and timeline of the
wider ZAMSTAR study, thus reflecting the develop-
ment and administration of TB stigma items in the
trial.
At the start of the trial in 2005, baseline research
included qualitative enquiry and tuberculin skin test
(TST) surveys in all 24 communities.10,11 Trial
interventions were delivered between 2006 and
2009.2 There were two interventions, household
counselling and enhanced case finding (ECF), rand-
omised in a factorial design so that 6 communities
were randomised to standard-of-care, 6 to ECF alone,
6 to household counselling alone, and 6 to both ECF
and household interventions.2 Twelve communities
were thus randomised to receive the household-level
intervention and 12 did not receive the household
intervention. In all communities, delivery of TB
services at governmental health facilities and the
integration of TB and HIV services were optimised. A
TB prevalence survey, and follow-up of the TST
survey cohort of schoolchildren, were both conducted
in 2010 to measure the effect of the trial interven-
tions. Primary trial findings suggested that the
household counselling carried out in TB patient
households reduced TB prevalence and transmission
at community level.2 There was little evidence of any
impact of ECF on TB prevalence or transmission.2
Household counselling intervention
The household-level intervention provided TB screen-
ing and HIV counselling and testing for all household
members. In addition, practical, clinical and emo-
tional support was provided to TB patients and to all
adults who were members of their household through
visits to the households at least three times during the
course of the anti-tuberculosis treatment (see Appen-
dix for further details on the household interven-
tion).* The intervention was not designed with
reduction of TB or HIV stigma as a primary aim.
However, it was expected that household counsellors
would help households manage forms and the
consequences of TB and HIV stigma if these were
evident during household visits. It was also possible
that the household intervention might instigate
stigma experiences by increasing the visibility of TB
patients, who are often assumed to also have HIV.12
Secondary Outcome Cohort Study surveys
The aim of the Secondary Outcome Cohort Study
(SOCS) was to recruit 150 TB-affected households in
each of the 24 communities. The sample size was
Figure 1 ZAMSTAR CRT and TB stigma item timelines. ZAMSTAR¼ Zambian and South African
TB and HIV Reduction study; CRT¼cluster-randomised trial; TB¼ tuberculosis; TST ¼ tuberculin
skin test, SOCS¼ Secondary Outcome Cohort Study; HH¼ household. This image can be viewed
online in colour at http://www.ingentaconnect.com/content/iuatld/ijtld/2017/00000021/
a00111s1/art00009
*The appendix is available in the online version of this article, at
http://www.ingentaconnect.com/content/iuatld/ijtld/2017/
00000021/a00111s1/art00009
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calculated to be able to measure trial outcomes and to
be practical. Households were recruited from among
index TB patients initiating anti-tuberculosis treat-
ment at government TB diagnostic health facilities
after the start of the trial. TB patients were followed
up twice at intervals of approximately 18 months.
Three rounds of SOCS and stigma items were thus
administered twice to TB patients and their adult
household members, in SOCS1 (September 2006–
August 2008) and in SOCS2 (August 2008–October
2009), with approximately 18 months between
interviews. In SOCS2, the items were asked in the
same way as at SOCS1 to accommodate any newly
diagnosed TB patients. SOCS1 was completed close
in time to the TB patient’s diagnosis; in communities
receiving the household intervention, SOCS1 enrol-
ment was done before the household was offered the
intervention. All adults (aged 715 years) and
children (,5 years) living in the same household as
a TB patient were invited to participate. Participants
were asked to respond to a structured questionnaire
that included TB and HIV stigma items. Other
components of the questionnaire included alcohol
use, sexual behaviour, experience of TB and HIV
treatment, and (in SOCS2 only) mental health. HIV
counselling and rapid HIV testing were offered as a
service, and a venous blood sample was collected for
laboratory HIV testing.
Development and reduction of tuberculosis stigma
indicators
In 2004–2006, indicators for measuring TB stigma
were much less developed than indicators in the HIV
field. This made TB stigma items more experimental
and unusual. The HIV epidemic had, at the time,
swung attention back to health-related stigma.
Building on a qualitative multi-country study,13
Nyblade et al. pilot-tested HIV stigma indicators in
Tanzania.14 This pilot has formed the foundation for
much HIV stigma measurement subsequently. These
HIV stigma indicators drew on the key conceptual
domains of stigma.15 Drawing on these, and more
limited work on TB stigma scales, especially among
TB patients,16 VB considered at household level how
diagnosed TB patients, PLHIV and other household
members might each express and experience stigma.
For example, internalised stigma is an essential
domain among TB patients and PLHIV, whereas
secondary stigma is an essential domain for other
household members. VB and JRH followed the
mixed-methods approach advocated by Van Brakel17
for stigma research, and drew upon earlier qualitative
research conducted by Bond in Zambia during 2001–
2007 to provide insights on key TB stigma domains
(Appendix Table A.1). Forty items specific to TB
stigma, and grouped according to domains, were
developed to be administered to TB patients and/or
household members.
The items were piloted prior to SOCS1 by trained
research assistants in four Zambian communities, in
English and three Zambian languages (Nyanja,
Bemba and Tonga), and in two South African
communities in English, isiXhosa and Afrikaans. All
items were translated and back-translated.
Following the administration of the 40 TB stigma
items in SOCS1 and SOCS2, we developed a
‘favoured’ and ‘reduced’ set of items. Preliminary
analysis of baseline data summarised frequencies and
percentages overall and disaggregated according to
country, community and sociodemographic charac-
teristics (age, sex, education, rural/urban, language).
We then drew again on qualitative data and key
literature and held discussions with the trial investi-
gators, statisticians and other social scientists. Trans-
lations were also re-reviewed and only items whose
meaning was consistently conveyed across different
languages were retained for further analysis.
Key literature published since the items were first
developed included a TB stigma scale16 looking at
community and patient perspectives (23 indicators,
covering causes, moral values and consequences) and
an internalised social stigma scale18 adapted from a
mental illness scale measuring four dimensions
(alienation, perceived discrimination, endorsement
of stereotypes and social withdrawal). The latter
helped determine which of our items should be
retained to address gaps in existing scales. One gap
included a paucity of more comprehensive stigma
data from TB patients about themselves. For exam-
ple, Van Rie et al. asked TB patients to recall the
experiences of ‘other patients’,16 and Macq et al.
focused exclusively on internalised stigma experienc-
es of TB patients.18
The final selection of a ‘favoured set’ was deter-
mined by the ability of the indicator to: measure both
TB and HIV; capture different domains of stigma
(casual transmission myths; shame, blame and judge-
ment; enacted stigma; internal stigma; and disclosure);
capture responses from both household members and
TB patients; measure domains that the interventions
might impact; address a gap in the literature;
frequencies at baseline; and be consistently translated.
The process of selection and reduction resulted in
14 items across seven pre-specified domains of TB
stigma, of which four were asked of household
members and 10 of TB patients (Table 1). For the
four domains of stigma, we developed indicators
drawing on a single binary item (Table 1). For the
three remaining domains, which drew on 3 or 4
binary items, we developed a simple summary
indicator denoting whether respondents answered
affirmatively to at least one of the items. A formal
scale development process was not appropriate given
the form of the data (yes/no for each item) and the
small number of items within each pre-specified
domain.
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Data collection
Once written informed consent had been obtained,
the research questionnaire was administered using
paper copies by research assistants paired with a
nurse/counsellor. Often, but not always, respondents
were interviewed by the same pair at SOCS1 and
SOCS2. The questionnaires took around 40 min on
average to administer.
Ethics
Ethics clearance was obtained from the Biomedical
Ethics Committee at the University of Zambia,
Lusaka, Zambia; the Stellenbosch Health Research
Ethics Committee, Tygerberg, South Africa; and the
London School of Hygiene & Tropical Medicine
Ethics Committee, London, UK. Governmental ap-
proval for the trial was obtained in both countries.
Study and analysis population
The study population was all adult TB patients and
adult members of their households (with no TB) who
consented to participate in SOCS1. The analysis
population for measuring the effect of the household
intervention on stigma outcomes was the population
that was retained at SOCS2 (Table 2).
Analysis
For each of the seven stigma domains, we summarised
their prevalence at SOCS1, at SOCS1 with restriction
to adults who were followed up at SOCS2, and at
Table 1 Refined TB stigma indicator set
Population group Domain Items
Proportion who
responded agree/yes
% Indicator coding*
Household members
of TB patient
Transmission myths You can catch TB if you touch a patient
who is diagnosed as having TB
5.8 1 ¼ agrees with one of
these untrue statements
0 ¼ disagrees with allYou can catch TB by sharing eating utensils
with someone who has TB
20.2
You can catch TB from having sex with
someone who has TB
24.1
Household members
of TB patients
Blame TB is a punishment for bad behaviour 10.3 1 ¼ agree
0 ¼ disagree
TB patients Experience of social
exclusion
Since you fell sick with TB have you
experienced any of the following:
1 ¼ answer yes to any one
of these experiences
0 ¼ answers no to all Been excluded from a social gathering 2.8
 Abandoned by spouse/partner 2.8
 Isolated by your household 2.8
 Your children or family have been
isolated/shunned
1.5
TB patients Experience of being
made fun of
Since you fell sick with TB have you
experienced any of the following:
1 ¼ answer yes to any one
of these experiences
0 ¼ answers no to all Lost respect or standing in the
community
6.4
 Been teased, insulted or sworn at 11.2
 Been gossiped about 18.6
TB patients Experience of health-
setting stigma
Since you fell sick with TB have you
experienced any of the following:
1 ¼ yes
0¼ no
 Been treated worse than patients with
other diseases by health staff
1.8
TB patients Internalised stigma Since you were diagnosed with TB have
you felt:
1 ¼ yes
0¼ no
 Unclean or dirty because of your TB 8.7
TB patients Disclosure Have you told anyone outside of your
household about your TB diagnosis?
72.3 1 ¼ yes
0¼ no
*Answers indicative of stigma were coded ‘10 and answers indicative of no stigma were coded ‘00.
TB¼ tuberculosis.
Table 2 SOCS study cohorts at baseline and follow-up
TB patients Household members of TB patients
Household counselling
n
No household counselling
n
Household counselling
n
No household counselling
n
Baseline 2434 2193 2501 2321
Excluded from follow-up analysis* 1501 1300 1294 1212
Incident TB† NA NA 40 39
Analysis population at follow-up 933 (38% of cohort) 893 (40% of cohort) 1167 (45% of cohort) 1068 (44% of cohort)
* Individuals with no follow-up, unknown TB status, missing data.
† Individuals with incident TB were also excluded from the analysis population at follow-up.
SOCS¼ Secondary Outcome Cohort Study; TB¼ tuberculosis; NA¼ not available.
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SOCS2, both overall and separately for Zambia and
South Africa.
Our main analysis was aimed at comparing the 12
communities that were randomised to receive the
household intervention with the 12 that were not for
stigma prevalence at the time of SOCS2. We present
both unadjusted and adjusted analyses, with adjusted
analysis using a two-stage approach that is standard
for a community-randomised trial with ,30 commu-
nities.2
For each stigma indicator, the proportion (preva-
lence) of each stigma indicator was calculated
separately for each community in the unadjusted
analysis; a log transformation was then applied to
reduce the skewness of the distributions. To compare
communities, the geometric mean of the proportions
was calculated for the 12 communities with the
household intervention, and the 12 communities
without the intervention. The effect of the interven-
tion was measured by a prevalence ratio (PR), equal
to the ratio of the two geometric means.
With regard to the primary endpoint of the trial,
the adjusted analysis was performed in two stages.4
The first stage was to fit a logistic regression model to
individual-level data, separately for Zambian and
Western Cape communities, adjusting for communi-
ty, household and individual characteristics as pre-
specified in the trial statistical analysis plan. The
logistic regression model was used to predict the
expected number (E) of adults with the stigma
outcome, under the null hypothesis of no household
intervention effect. The ratio of observed (O) to
expected (E) events (O/E) was calculated for each
community, the geometric mean of O/E was calcu-
lated separately for communities with and without
the household intervention, and PRs for the house-
hold intervention effect were calculated as the ratio of
geometric means.
RESULTS
Study population
The study population comprised 1826 TB patients
and 1235 adult members of their households. At
baseline, the distribution of age, sex, education and
marital status was similar in household intervention
and non-household intervention communities among
both household members and TB patients (Table 3),
whereas household wealth was lower in household
communities. There was a higher proportion of men
among TB patients and a higher proportion of
women among household members, and a higher
proportion of TB patients in the 25–49 year age range
compared with those who were not TB patients. The
percentage of adults who were HIV-positive was high
among both household members and TB patients, at
around 30% and 65%, respectively. The sociodemo-
graphic profile of adults followed up at SOCS2 was
overall similar to the profile of all adults enrolled at
SOCS1, with a slight shift towards more women and
fewer younger adults.
Household-level tuberculosis stigma: transmission
myths and blaming patterns among household
members
Agreement with ‘fear and myths’ and with ‘blame’
was higher in Zambia than in South Africa at
baseline, and in both countries it was lower in the
household than the non-household arm. Restricting
our analysis to adults who were followed up, findings
at baseline were similar to those in the total study
population (Table 4).
At follow-up, agreement with ‘fear and myths’ and
with ‘blame’ was overall lower than at baseline, in
both Zambia and South Africa and in both household
and non-household communities (Table 4). At both
baseline and follow-up, there was substantial be-
tween-community variation, particularly in Zambia
(Figure 2).
Table 5 summarises the unadjusted and adjusted
analyses of whether the household intervention
reduced stigma. For ‘fear and myths’, the geometric
mean value of household intervention communities
was 13.2%, and this was 27.6% for non-household
intervention communities, with an unadjusted PR of
0.48 (95% confidence interval [CI] 0.16–1.38). The
association was weakened after adjustment, with a
PR of 0.61. There was no statistical evidence that the
household intervention reduced belief in transmission
myths or blaming patterns, but the CIs were wide and
for both outcomes the PR was ,1 (Figure 1,
Appendix Table A.2).
Tuberculosis patients’ experiences of stigma
At baseline, ‘being made fun of’ was the most
common form of stigma reported by TB patients
(Table 4), more common in Zambia than in South
Africa. The prevalence of internalised stigma was
higher in the non-household than in the household
communities in both countries. Over half of TB
patients had told someone outside of their household
about their TB diagnosis, except for TB patients in
South African household communities, where the
prevalence of disclosure was 35%. There were large
variations across communities in the prevalence of
being made fun of, internalised stigma and disclosure
of TB status. The prevalence of social exclusion was
relatively low, and there were few reports of health-
setting stigma.
In Zambia, the prevalence of ‘being made fun of’
was lower at follow-up than at baseline in the
household communities, and higher in the non-
household communities, with opposite findings in
South Africa (Table 4). Once adjusted, there was little
statistical evidence that the household intervention
reduced the prevalence of this outcome (adjusted PR
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¼ 0.89, Table 5). The prevalence of social exclusion
and experience of health-setting stigma changed little
between baseline and follow-up (Table 5). The
prevalence of disclosure of TB status increased in
household and non-household communities in both
Zambia and South Africa.
The prevalence of internalised stigma fell in the
household communities in both Zambia and South
Africa, and also in the non-household communities in
South Africa, but increased in the non-household
communities in Zambia (aPR 0.85, but with wide
95% CIs) (Figure 1).
DISCUSSION
This CRT provided a rare opportunity to develop,
apply, refine and assess a TB item set within a CRT to
measure the impact of an intervention. Fourteen
items across seven TB stigma domains included
longitudinal perspectives of both household members
(n ¼ 1253) and TB patients (n ¼ 1826). Qualitative
data helped develop the indicators. Our objectives
were to develop TB stigma items and to measure if a
household intervention that was not designed with
stigma reduction as a core aim, but which was
successful in improving TB management and reduc-
ing TB prevalence, may also reduce TB stigma.
Overall, we found little evidence that the forms of
stigma we measured were reduced by the household
intervention. Some, but not all, types of stigma were
reduced over time in both arms of the trial.
The large between-community variation in re-
ported TB stigma limited our ability to show an
effect of the household intervention on TB stigma;
however, it did highlight the powerful influence of
context at both community and country levels. The
Table 3 Sociodemographic characteristics of the study population at baseline and follow-up
Baseline Follow-up
Household member TB patient Household member TB patient
Household
n (%)
Non-household
n (%)
Household
n (%)
Non-household
n (%)
Household
n (%)
Non-household
n (%)
Household
n (%)
Non-household
n (%)
n 2501 2321 2434 2193 1175 1069 935 896
Sex
Male 788 (31.5) 705 (30.4) 1320 (54.2) 1125 (51.3) 317 (27) 294 (27.5) 470 (50.3) 435 (48.5)
Female 1713 (68.5) 1616 (69.6) 1113 (45.7) 1068 (48.7) 858 (73) 775 (72.5) 465 (49.7) 461 (51.5)
Unknown 0 0 1 (0) 0 0 0 0 0
HIV status
HIV-negative 1710 (68.4) 1556 (67) 741 (30.4) 627 (28.6) 802 (68.3) 727 (68) 273 (29.2) 248 (27.7)
HIV-positive 679 (27.1) 660 (28.4) 1562 (64.2) 1463 (66.7) 353 (30) 319 (29.8) 657 (70.3) 639 (71.3)
Indeterminate/unknown 112 (4.5) 105 (4.5) 131 (5.4) 103 (4.7) 20 (1.7) 23 (2.2) 5 (0.5) 9 (1.0)
Age group, years
15–24 932 (37.3) 923 (39.8) 435 (17.9) 384 (17.5) 353 (30) 351 (32.8) 113 (12.1) 104 (11.6)
25–29 327 (13.1) 315 (13.6) 449 (18.4) 390 (17.8) 159 (13.5) 150 (14) 157 (16.8) 156 (17.4)
30–34 277 (11.1) 242 (10.4) 523 (21.5) 455 (20.7) 121 (10.3) 116 (10.9) 197 (21.1) 167 (18.6)
35–39 195 (7.8) 178 (7.7) 400 (16.4) 366 (16.7) 111 (9.4) 103 (9.6) 166 (17.8) 163 (18.2)
40–49 316 (12.6) 262 (11.3) 400 (16.4) 358 (16.3) 169 (14.4) 120 (11.2) 187 (20) 181 (20.2)
750 437 (17.5) 392 (16.9) 216 (8.9) 229 (10.4) 260 (22.1) 229 (21.4) 114 (12.2) 124 (13.8)
Unknown 17 (0.7) 9 (0.4) 11 (0.5) 11 (0.5) 2 (0.2) 0 1 (0.1) 1 (0.1)
Highest school grade attended
None/grade 1–2 258 (10.3) 208 (9) 213 (8.8) 175 (8) 128 (10.9) 104 (9.7) 79 (8.4) 67 (7.5)
Grade 3–6 416 (16.6) 326 (14) 446 (18.3) 362 (16.5) 192 (16.3) 145 (13.6) 182 (19.5) 138 (15.4)
Grade 7–10 1274 (50.9) 1147 (49.4) 1249 (51.3) 1105 (50.4) 632 (53.8) 534 (50) 468 (50.1) 485 (54.1)
Grade 11–12 435 (17.4) 468 (20.2) 387 (15.9) 397 (18.1) 182 (15.5) 200 (18.7) 148 (15.8) 137 (15.3)
College/university 102 (4.1) 159 (6.9) 130 (5.3) 141 (6.4) 41 (3.5) 86 (8) 58 (6.2) 69 (7.7)
Unknown 16 (0.6) 13 (0.6) 9 (0.4) 13 (0.6) 0 0 0 0
Marital status
Single 1103 (44.1) 999 (43) 971 (39.9) 909 (41.5) 475 (40.4) 428 (40) 350 (37.4) 369 (41.2)
Married 1111 (44.4) 1029 (44.3) 1031 (42.4) 859 (39.2) 529 (45) 463 (43.3) 444 (47.5) 373 (41.6)
Widowed 171 (6.8) 178 (7.7) 169 (6.9) 195 (8.9) 128 (10.9) 127 (11.9) 80 (8.6) 81 (9)
Separated 110 (4.4) 113 (4.9) 257 (10.6) 230 (10.5) 41 (3.5) 49 (4.6) 60 (6.4) 71 (7.9)
Unknown 6 (0.2) 2 (0.1) 6 (0.2) 0 2 (0.2) 2 (0.2) 1 (0.1) 2 (0.2)
Household wealth index*
Poorest 551 (22) 244 (10.5) 594 (24.4) 338 (15.4) 265 (22.6) 109 (10.2) 211 (22.6) 126 (14.1)
2nd quartile 880 (35.2) 443 (19.1) 866 (35.6) 481 (21.9) 403 (34.3) 172 (16.1) 312 (33.4) 204 (22.8)
3rd quartile 481 (19.2) 671 (28.9) 479 (19.7) 651 (29.7) 216 (18.4) 302 (28.3) 217 (23.2) 282 (31.5)
Wealthiest 547 (21.9) 926 (39.9) 449 (18.4) 702 (32) 291 (24.8) 486 (45.5) 195 (20.9) 284 (31.7)
Unknown 42 (1.7) 37 (1.6) 46 (1.9) 21 (1) 0 0 0 0
*Calculated using the first principal component of a principal components analysis including: does the household own a radio, television, fridge, bicycle,
motorbike, or car; does the household have a non-family domestic worker; type of water source; type of toilet facilities; type of flooring; does the household own a
digital video disc (DVD) player (South Africa only).
TB¼ tuberculosis; HIV¼ human immunodeficiency virus.
S54 The International Journal of Tuberculosis and Lung Disease
prevalence of the two stigma domains (transmission
myths and blame) that we measured among house-
hold members of TB patients declined over time in
both arms and in both countries, and in most
communities. Fear of being infected with TB is a
key cause of TB stigma.19–21 This may indicate that
households that participated in the study became
more aware of TB issues over time, or that the study
had been undertaken at a time of changing overall
trends in TB stigma. Another possibility is that a
‘Hawthorne effect’ meant that participation in the
SOCS research reduced this form of stigma and that
there was no additional effect from the household
intervention. Holding TB patients culpable for their
infection is another key cause of TB stigma.12,22 In
South Africa, a history of being familiar with
prevalent TB combined with the potential of
household counsellors to discourage blame could
have influenced the more subdued culpability.23
Among TB patients, all three indicators of stigma
experienced were well balanced at baseline and
changed little over time; also, there was little evidence
of an impact of the household intervention. These
three indicators of TB stigma experienced among TB
patients are particularly valuable because this type of
evidence is unusual. Other scales have focused more
on TB patient experiences of internalised stigma,18
experiences of ‘other’ TB patients,16,24 fears of
transmission and shame12 and health facility stig-
ma.22 A multi-country study in Bangladesh, India,
Table 4 Prevalence of A) household member and B) TB patient TB stigma at baseline and follow-up*
A)
Zambia South Africa Overall
Household
n (%)
Non-household
n (%)
Household
n (%)
Non-household
n (%)
Household
n (%)
Non-household
n (%)
Baseline
Household members, n 1463 1596 1038 725 2501 2321
Fears and myths 715 (48.9) 941 (59) 215 (20.7) 229 (31.6) 930 (37.2) 1170 (50.4)
Blame 200 (13.7) 323 (20.2) 51 (4.9) 124 (17.1) 251 (10) 447 (19.3)
Baseline†
Household members, n 718 834 457 235 1175 1069
Fears and myths 348 (48.5) 486 (58.3) 89 (19.5) 73 (31.1) 437 (37.2) 559 (52.3)
Blame 96 (13.4) 176 (21.1) 21 (4.6) 40 (17) 117 (10) 216 (20.2)
Follow-up
Individuals included in analysis at follow-up, n 718 834 457 235 1175 1069
Fears and myths 205 (28.6) 385 (46.2) 74 (16.2) 53 (22.6) 279 (23.7) 438 (41)
Blame 51 (7.1) 153 (18.3) 9 (2) 19 (8.1) 60 (5.1) 172 (16.1)
B)
Zambia South Africa Overall
Household
n (%)
Non-household
n (%)
Household
n (%)
Non-household
n (%)
Household
n (%)
Non-household
n (%)
Baseline
TB patients, n 1550 1205 884 988 2434 2193
Experience of social exclusion 101 (6.5) 116 (9.6) 20 (2.3) 46 (4.7) 121 (5) 162 (7.4)
Experience of being made fun of 433 (27.9) 307 (25.5) 23 (2.6) 85 (8.6) 456 (18.7) 392 (17.9)
Experience of health-setting stigma 14 (0.9) 36 (3) 4 (0.5) 14 (1.4) 18 (0.7) 50 (2.3)
Internalised stigma 61 (3.9) 179 (14.9) 37 (4.2) 178 (18) 98 (4) 357 (16.3)
Disclosure 876 (56.5) 744 (61.7) 292 (33) 672 (68) 1168 (48) 1416 (64.6)
Baseline†
TB patients, n 636 574 299 322 935 896
Experience of social exclusion 44 (6.9) 46 (8) 7 (2.3) 22 (6.8) 51 (5.5) 68 (7.6)
Experience of being made fun of 208 (32.7) 135 (23.5) 9 (3) 36 (11.2) 217 (23.2) 171 (19.1)
Experience of health-setting stigma 5 (.8) 19 (3.3) 0 (0) 5 (1.6) 5 (.5) 24 (2.7)
Internalised stigma 21 (3.3) 75 (13.1) 15 (5) 57 (17.7) 36 (3.9) 132 (14.7)
Disclosure 383 (60.2) 374 (65.2) 105 (35.1) 216 (67.1) 488 (52.2) 590 (65.8)
Follow-up
Included in analysis at follow-up, n 636 574 299 322 935 896
Experience of social exclusion 47 (7.4) 65 (11.3) 9 (3) 9 (2.8) 56 (6) 74 (8.3)
Experience of being made fun of 157 (24.7) 187 (32.6) 17 (5.7) 16 (5) 174 (18.6) 203 (22.7)
Experience of health-setting stigma 3 (0.5) 20 (3.5) 5 (1.7) 5 (1.6) 8 (.9) 25 (2.8)
Internalised stigma 17 (2.7) 102 (17.8) 4 (1.3) 37 (11.5) 21 (2.2) 139 (15.5)
Disclosure 478 (75.2) 437 (76.1) 157 (52.5) 251 (78) 635 (67.9) 688 (76.8)
* The prevalence values reported for each outcome were calculated by first calculating the prevalence at SOCS2 in each of the 24 communities, and then
calculating the geometric mean of the 12 values for the communities that received the household intervention and the 12 values for the communities that did not
receive the intervention.
† Prevalence of indicators at baseline, with restriction to individuals who were followed up at SOCS2. These values are shown to ascertain whether the prevalence
of reported stigma was similar among those who were followed up at SOCS2 compared with all who were enrolled in the study.
TB¼ tuberculosis; SOCS¼ Secondary Outcome Cohort Study.
TB stigma and household interventions S55
Figure 2 Community level variation in household member TB stigma. TB¼ tuberculosis; SOCS¼Secondary Outcome Cohort Study.
This image can be viewed online in colour at http://www.ingentaconnect.com/content/iuatld/ijtld/2017/00000021/a00111s1/
art00009
Table 5 Stigma levels among household members and TB patients at SOCS2
Indicators Intervention
Unadjusted Adjusted*
Geometric mean
prevalence PR (95%CI) P value PR (95%CI) P value
Household members
Fears and myths Non-household 27.6 — — — —
Household 13.2 0.48 (0.16–1.38) 0.159 0.61 (0.26–1.44) 0.237
Blame Non-household 9.9 — — — —
Household 3.8 0.38 (0.16–0.93) 0.036 0.77 (0.48–1.25) 0.276
TB patients
Social exclusion Non-household 6.4 — — — —
Household 4.5 0.71 (0.33–1.50) 0.347 0.78 (0.45–1.35) 0.350
Being made fun of Non-household 13.1 — — — —
Household 12.1 0.92 (0.39–2.17) 0.846 0.89 (0.45–1.75) 0.713
Health-setting stigma Non-household 2.4 — — — —
Household 1.5 0.61 (0.31–1.22) 0.151 0.61 (0.31–1.20) 0.143
Internalised stigma Non-household 9.5 — — — —
Household 2.1 0.22 (0.09–0.54) 0.002 0.85 (0.41–1.76) 0.641
Disclosure Non-household 74.8 — — — —
Household 64.2 0.86 (0.69–1.06) 0.148 0.97 (0.83–1.14) 0.741
*Adjusted for community-level prevalence of infection with M. tuberculosis at baseline as measured in schoolchildren in 2005 and classified into two strata (high
and low) in each of Zambia and South Africa, age group, sex, education, marital status, household wealth index, HIV status at the time of SOCS1, community-level
HIV prevalence as measured in a prevalence survey in 2010, and community-level prevalence of stigma at baseline (at the time of SOCS1).
SOCS¼ Secondary Outcome Cohort Study; TB¼ tuberculosis; PR¼ prevalence ratio; CI¼ confidence interval; HIV¼ human immunodeficiency virus.
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Malawi and Columbia is most similar to our
indicator set for TB patients, covering similar, but
less clearly demarcated, domains across 18 indica-
tors.25 ‘Being made fun of’ was the most prevalent
form of TB stigma experienced, especially in Zambia.
Gossip (a component of being made fun of) was
documented as a concern among TB patients in
Pakistan, but not in Nepal or Bangladesh.26,27 Gossip
is also a strong form of HIV-related stigma.28 In
South Africa, the low reported experience of social
exclusion could reflect tolerance towards TB patients
and historical familiarity with TB. This could also be
due (at least in part) to limited space and options for
managing TB patients. Despite a possible social
desirability bias in the reporting of the health-setting
stigma experienced, low levels of this form of stigma
are consistent with low levels of obvious stigma
towards TB patients in health facilities, which has
also been documented among health workers in the
Free State Province of South Africa.29
Internalised stigma was measured using an item
that asks TB patients if they feel ‘unclean or dirty
because of having TB’. This translated as meaning
that the patient felt he was ‘not pure’ because of
suffering from TB. Overall levels fell over time, which
was encouraging. However, CIs for the effect of the
household intervention on internalised stigma were
wide and we did not find statistical evidence for any
effect of the intervention on this outcome. It is
possible that the reduction in internalised stigma
reflected growing acceptance of having had TB over
time as treatment progressed and was completed. In
Nicaragua, multilevel and faceted interventions
reduced internalised stigma over a shorter period of
time.30
Disclosure to anyone outside the household was
relatively high at baseline, except for South African
household communities, and increased in both arms
at follow-up. Over time, TB patients may have had
more contact with TB services (including the house-
hold intervention) and this may have facilitated their
decision to tell others. They may also have felt less ill
and more able to share their diagnosis, and this could
have been supported by household counsellors.
Disclosure has a complex relationship with stigma.
Although not disclosing can be an indication of it
being unsafe to disclose, the act of disclosure itself can
enhance the opportunity and experience of stigma.
Variations at community and country levels in all
stigma indicators deserve attention. No strong
consistent pattern could be discerned across indica-
tors or, for example, between levels of stigma and
disclosure. The open/closed (homogeneous/heteroge-
neous) features of communities may have influenced
the imbalance at baseline across study arms (there
were more closed communities in the non-household
counselling arm in Zambia) and the pattern of blame
in less open communities in South Africa.31,32
However, this is only a partial explanation. Commu-
nity variability indicates the complex and dynamic
nature of stigma and demands that we pay more
attention to the influence of localised stigma. This has
been pointed out by others using different approach-
es. Specific histories can shape stigma more than
specific conditions.33 Kipp et al. also highlighted the
danger of population-level stigma missing what is
happening with particular groups.34 Macq et al.
argued the importance of local contexts, the need for
multifaceted interventions, and for the adaptability of
interventions over time.30 Newell et al. and Chang et
al. also emphasised variability in patterns of TB
stigma across countries and cultures (e.g., around
causes and knowledge and health responses).35,36
Our analysis also suggests that localised experiences
of stigma are significantly different.
Study limitations
The present study also had limitations. Loss to
follow-up among the cohort was high, although the
characteristics of those who were or were not
followed up at SOCS2 were broadly similar. Statis-
tical power to show a difference between the study
arms was relatively low due to the large between-
community variation in TB stigma. There was
substantial baseline imbalance between the study
arms for some measures of TB stigma, although our
analysis attempted to adjust for this. There may also
have been reporting bias, and specifically the link
between the health facility and the intervention,
coupled with limited health options for managing
TB, could have made it hard for TB patients to
criticise TB services. Furthermore, training of re-
search assistants focused on technical processes, and
more intensive and reflexive value clarifications that
are recommended for sexual behaviour, alcohol and
stigma research were relatively limited. In addition,
time, experience and interviewer/interviewee inter-
pretation could have influenced the responses of
household members and TB patients at SOCS2. For
example, at follow-up, TB patients were reflecting on
a greater length of time with TB (as opposed to
baseline, when they were within 2 months of
diagnosis), with most of them cured of TB and most
co-infected with HIV. The selected items were not
adjusted to reflect this period between survey rounds
(for example, ‘since we last saw you’/‘in the last 12
months’), but this had the advantage that we could
capture the cumulative experience of TB patients
from when they were first diagnosed with TB,
through TB treatment, and after TB treatment.
CONCLUSION
We developed a carefully considered set of TB stigma
items across key TB stigma domains using a robust
mixed-method approach. These items were included
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in a cohort study to measure the outcomes of a CRT
in 24 communities in Zambia and South Africa. The
items included in this analysis were administered
twice to 1826 TB patients and 1235 adults living in
the household of a TB patient across the communi-
ties. Our analysis suggested that improved manage-
ment of TB at the household level did not
substantially reduce TB stigma, but also showed that
stigma levels varied substantially across communities
and countries.
Our findings are useful for TB control pro-
grammes. At household level, isolation of TB
patients, myths about TB transmission and making
TB patients culpable for their illness need addressing,
particularly in Zambia, and could possibly be
reduced with improved TB management. Internalised
stigma and the experience of being made fun of
emerge as more persistent and prevalent, and they
may be responsive to intervention. Experiences of
social exclusion and of health-setting stigma were
encouragingly low (particularly in South Africa) and
reflect a degree of familiarity with and tolerance
about TB. We recommend that future TB interven-
tions should include stigma-specific interventions
rather than relying on better management of TB
alone if a goal is to reduce TB stigma. Furthermore,
we believe that mixed methods and interdisciplinary
enquiry are needed for a better understanding about
variations in stigma levels across different settings
and any influences of subgroups, localised experienc-
es and past events.
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APPENDIX
Household counselling intervention
The Zambian and South African TB and HIV
Reduction (ZAMSTAR) Study, a factorial cluster
randomised controlled trial, was used to test two
interventions that were carried out in combination or
independently across 24 communities and then
compared, both with each other, combined and with
control sites where there were no tuberculosis (TB)
interventions beyond the integration of TB and
human immunodeficiency virus (HIV) services at
government TB diagnostic health facilities. The two
interventions were enhanced case-finding (which had
four components: community mobilisation; open
access/fast-track sputum collection points at the
clinic; sputum collection points in the community;
school interventions) and a household intervention.1
The household intervention is the focus of this stigma
analysis because the intervention had a significant
impact on TB prevalence.1
The household intervention was a strategy of
combined TB-HIV activities based on World Health
Organization guidelines for collaborative TB-HIV
care2 at the household level using a newly diagnosed
TB patient as a gateway to a household at risk of TB
and HIV. Household counsellors (nurse or lay
counsellors) were trained using a standardised
curriculum by the same trainers in the two countries.
Anti-stigma education was not a major component of
the household counselling training. However, one
training session raised the issue of encountering
stigmatising views among household members and
asked household counsellors to brainstorm strategies
for challenging any stigmatising views. These coun-
sellors visited the household of all newly diagnosed
TB patients at least thrice during the patient’s
treatment (treatment start, month 2 and treatment
end) with the written consent of the TB patient, and
provided support to the TB patient during the course
of anti-tuberculosis treatment. In addition, counsel-
lors provided TB-HIV education, TB symptom
screening (using a standardised symptom checklist
with referral for sputum examination for any
screening-positive individuals), HIV counselling and
testing, linkage to HIV care, adherence support and
isoniazid preventive therapy to all consenting house-
hold members. Household members provided written
informed consent to participate in the intervention.
Households did not receive any incentives to be
included in the intervention, except for visits by
counsellors and the support and services that they
offered. Household counsellors actively supported TB
staff at government health facilities when they were
not in the field visiting clients. Both unpublished
qualitative ZAMSTAR research exploring the role of
household counselling and published ethnographic
research in Zambia documented household counsel-
lors providing emotional support and detailed infor-
mation on TB transmission when TB patients shared
experiences of TB stigma during household counsel-
ling visits (Bond V & M’lewa S. Preliminary analysis
of household counselling evaluation in 3 Zambian
communities in 2008. Personal communication, May
2017).3 Due to a combination of better TB manage-
ment and the potential role of household counsellors
in helping manage stigma, the household intervention
could impact some aspects of stigma.
As health systems in Zambia and South Africa are
different, interventions were applied as appropriate
for the country situation. For example, as in Zambia
TB smear microscopy is performed at on-site labora-
tories, additional microscopists were provided to
cope with increased demand; in South Africa, on the
other hand, as all sputum samples are sent to the
centralised TB testing laboratories of the National
Health Laboratory Service (NHLS), the system of
recording and reporting of samples and results in the
intervention clinics was strengthened.
Development and reduction of TB stigma items
To develop the TB stigma items, Bond and Har-
greaves drew on a mixed-method approach:4 a body
of qualitative data, a literature review, the discussions
and outputs of an International Consortium for
Research and Action Against health-related Stigma
(ICRAAS) and the development of HIV stigma
indicators. The TB stigma measurement field was
more unusual and experimental.
Qualitative data included research in Zambia and
South Africa that Bond had been directly involved
with since 2001. In a multi-country study on HIV
stigma (2001–2003) in Zambia, Tanzania and Ethio-
pia,5 the Zambian component included a particular
focus on TB stigma.6,7 This interest in TB stigma was
sustained through the collaborative health-related
stigma considerations of ICRAAS and Bond’s and
Weiss’s particular interest in TB stigma within this
group.8,9 At the beginning of ZAMSTAR, qualitative
data were collected using a ‘broad brush’ survey
approach in all 24 communities,8 as well as baseline
intensive data in more limited communities, from
2005 to 2006. Ethnographic fieldwork in two
communities (one Zambian, one South African) from
2006 to 2007 presented another opportunity for
understanding TB stigma.3,10 Some key areas to
emerge out of this body of work was the usefulness
of conceptualising stigma around causes, forms and
consequences and the ability of community members
and TB patients to see links between all three,5 the
entanglement of TB with HIV stigma in areas with
high HIV prevalence,7 the powerful harm caused by
gossip,5 the overlap of TB stigma with cultural
infractions,11 the specificity of TB transmission
fears,7 and the differences in stigma and moral
community across different communities and settings
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(e.g., urban/rural, Zambia/South Africa).8 Table A.1
lists the initial full set of 40 TB stigma items and
includes some examples of qualitative data insights
into domains and items (Table A.1).
Bond also decided to include parallel measures for
HIV stigma where feasible and appropriate, these
being questions aimed at the same manifestations of
stigma with the same wording but asking participants
to relate these to either TB or to HIV (Figure A.1). An
additional 42 items specific to HIV stigma (often
parallel with TB items) were included to be admin-
istered to people living with HIV (PLHIV) and
household members. This is shown in Figure A.1,
with the full set of TB items listed in Table A.1. Any
items that were newly developed (mostly TB stigma
items) were piloted and reviewed by trained research
assistants in English and vernacular languages
(Nyanja, Bemba and Tonga in Zambia and Xhosa
and Afrikaans in South Africa). All items were
translated and back-translated. All the items were
included in the first and second round of the
Secondary Outcome Cohort Study (SOCS1 and
SOCS2).
Reducing the items to a favoured set
Some examples of which TB items were excluded and
why are given in Table A.1. As described in the main
article, given the small number of items within each
domain, and given the strong a priori theoretical
reasoning for the domains listed, we did not
undertake multifactorial analysis but rather used a
simple approach to condensing information on
multiple items within domains. This has the strong
advantage of drawing heavily on previous qualitative
research and making final indicators used in the
analysis simple to understand. A formal scale
development approach was not appropriate given
the form of the data we collected in this study (Figure
A.2).
To date, these TB items have also been used in
South Africa both by the PLHIV Stigma Index Group
and by a recent doctoral secondary data analysis at
the University of Stellenbosch, Tygerberg, South
Africa (Lopes C S C, Burger C & Burger R.
Investigating the health seeking behaviours of persons
Figure A.2 Reduced TB item set (see also Table 1 in the main
article). TB¼ tuberculosis.
Figure A.1 Parallel domains of TB and HIV stigma. TB¼ tuberculosis; HIV¼ human immunodeficiency virus; PLHIV¼ people living
with HIV.
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Table A.1 Full set of 40 TB items included in SOCS1 and SOCS2
Population
group Domains Items Examples of qualitative data, 2005
Reasons for retaining/dropping
item
Household members of TB patients
Transmission myths
You can catch TB if you touch a
patient who is diagnosed as
having TB
‘Some family members. . .do not
wash the TB patient for fear of
being infected’ (community
members, Z12)
‘Households do not let TB patients
mix their plates and cups with
everyone else’ (man, Z13)
‘My friends started asking me how
it feels to have sex with a woman
who lost her husband’ (man TB
patient, Z15)
Baseline agree frequencies
relatively high (especially in
Zambia) for sex and utensil fears.
Sex transmission fear links to
sexual infractions around contact
with a woman who has aborted
or been widowed. Touch and
isolation lower; retained touch
because grouped better
You can catch TB by sharing eating
utensils with someone who has
TB
You can catch TB from having sex
with someone who has TB
TB patients should be isolated from
others in the community
Shame and blame
It is women who spread TB in our
communities
‘TB patients are blamed for
catching TB. . .they are usually
those who liked going out at
night’ (community members, Z2)
‘. . .in some cases wives. . .have
been blamed’ (women, Z2)
‘. . .most people with TB are
prostitutes’ (women, Z10)
Women/men/outsiders dropped:
prevalent but same individuals
agree with all three. ‘Careless’
sometimes translated as
‘promiscuous’. Retained
‘punishment for bad behaviour’;
highest prevalence of last 4
items, covariance fair, best
translation
It is men who spread TB in our
communities
It is outsiders who spread TB in our
communities
TB is a punishment for bad
behaviour
TB patients are careless
TB patients are disgusting
TB patients are promiscuous
Enacted stigma
Do you know/since we last saw
you, do you personally know
anyone with TB who has
experienced the following:
 Been excluded from a social
gathering
 Abandoned by spouse/partner
 Isolated by household
 Lost housing/denied housing for
rent
 Lost respect or standing in the
community
 Been teased, insulted or sworn at
 Been gossiped about
 Whose children or family have
been isolated/shunned
 Been treated worse than patients
with other diseases by health
staff
‘People with TB. . ..are blamed for
their sickness’ (woman, Z1)
‘. . .some TB patients have been
chased from their home’
(community members, Z2)
‘. . .wives have been chased from
their matrimonial home’
(women, Z2)
‘. . .friends literally taunted their
friend saying ‘You will die’’ (men,
Z3)
‘Her fellow pupils do not like
associating with her [girl with TB]
and she is constantly teased’
(community members, Z3)
Verbal insults and gossip the most
prevalent. Losing respect and
standing in the community next
most prevalent. Covariance fair.
Complex composite question
with less consequential and more
serious grouped together,
making any composite marker
dominated by most prevalent.
Not as powerful as what TB
patients said has actually
happened to them. Dropped all
of them in preference of
experience of TB patients
Disclosure
Have you/since we last saw you
have you personally come across
someone who has tried to hide
their TB diagnosis?
‘There is stigma in the
community. . .and that is why TB
patients do not like coming out
in the open’ (community
members, Z15)
Quite prevalent, indicator of
disclosure but not as powerful as
TB patient experience so
dropped.
TB-HIV association
Do you agree or disagree with the
following statements:
 TB is curable in those living with
HIV
 All TB patients have HIV/AIDS
‘When it comes to TB. . .because
they believe he/she also has HIV
and will die’ (women, Z5)
High agreement with first (TB is
curable in PLHIV) and low
agreement with second (all TB
patients have HIV). Dropped.
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Table A.1 (continued)
Population
group Domains Items Examples of qualitative data, 2005
Reasons for retaining/dropping
item
TB patients
Enacted stigma
Since you fell sick with TB have you
experienced any of the
following:
 Been excluded from a social
gathering
 Abandoned by spouse/partner
 Isolated by your household
 Lost housing/denied housing for
rent
 Lost respect or standing in the
community
 Been teased, insulted or sworn at
 Been gossiped about
 Your children or family have been
isolated/shunned
 Been treated worse than patients
with other diseases by health
staff
‘I had an experience when I was
very sick, looking thin. They
laughed at me. They used to say
’have you heard how he is
coughing?’ Sometimes I could go
and sit with them but they would
stand up and leave me alone’
(man TB patient, Z3)
‘My husband’s relatives were
saying, ‘no, just divorce her
because she’s not going to bear
any children’ (woman TB patient,
Z6)
‘A male doctor said to me...’ Take
your TB somewhere else. You
should keep a distance you will
give us TB. Stay away from
people because you do not take
care of yourselves’ (woman TB
patient, Z14)
Relatively low prevalence, with
gossip the most prevalent. Fairly
low covariance. However,
personal experiences of enacted
TB stigma more unusual and
needed for in TB field. Some
experiences more chronic
stressors, others more significant
events. Decision to split into
experience of social exclusion,
experience of being made fun of,
experience of health setting
stigma. One item dropped: ‘lost
housing/denied housing for rent’
due to very low prevalence
Internalised stigma
Do you think it is reasonable for
you to be treated in this way?
‘When I walk I feel bad. . .some
people think less of me’ (woman
TB patient, Z3)
‘I feel shy because some come to
see how serious my illness is and
others gossip saying that I am
HIVþ’ (man TB patient, Z14)
‘I also feel embarrassed to go to
church because I look inferior to
other women’ (woman TB
patient, Z14)
‘I feel uncomfortable going to that
TB corner because I feel like
everyone is looking and pointing
at me’ (man TB patient, Z8)
Relatively low prevalence of
agreement except for ‘less of
yourself’. However, latter
translation in some languages
problematic implying physically
diminished because of TB. Also
translation issues with ‘guilty’
and ‘careless’ sometimes
considered equivalent to
‘promiscuous’. Very low
prevalence of being afraid to be
seen at the TB corner/clinic.
Decision to retain ‘unclean or
dirty’ which was the closest to
low self-worth because of TB. In
most languages, it was
translated as ‘feeling as if you are
dirty/not pure because of
suffering from TB’
Since you were diagnosed with TB
have you felt:
 Less of yourself because of your
TB
 Guilty about having TB
 Unclean or dirty because of your
TB
 Careless to have got TB
 Afraid of being seen at the TB
corner clinic
Disclosure
Did you or have you tried to hide
your TB diagnosis from anyone?
‘I do come out in the open and
admit that I am sick and have TB.
I do not even pretend like others,
who say they have malaria, I just
tell the truth’ (man TB patient,
Z6)
Prevalence of hiding TB diagnosis
was low but prevalence of telling
anyone outside of the household
was much higher. Retained the
latter item as an indication of
disclosure
Did you tell or have you told
anyone outside of your
household about your TB
diagnosis?
TB¼ tuberculosis; SOCS¼ Secondary Outcome Cohort Study; HIV¼human immunodeficiency virus;þ¼positive; AIDS¼ acquired immune-deficiency syndrome.
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coughing for more than two weeks in Western Cape
South Africa, Preliminary PhD Analysis of ZAM-
STAR data, University of Stellenbosch, Tygerberg,
South Africa. Personal communication, 5May 2017).
The latter, which was restricted to the eight South
African communities, used the same reduced set of
seven TB stigma domains alongside other ZAMSTAR
data to identify patterns in health-seeking behaviour
in response to a cough. Their preliminary results
showed that stigma inhibits the likelihood of report-
ing having a cough for .2 weeks; however, the
significance of stigma tends to fall away when gender,
age and race were controlled for. The authors also
noted a significant variation in stigma levels across
communities. The PLHIV Stigma Index has not yet
shared the results of including these items in their
own work.
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R E´ S U M E´
CO N T E X T : Communaute´s de l’essai randomise´ en
grappes (CRT) du Zambian and South African TB
and HIV Reduction (ZAMSTAR), 2006–2009.
OB J E C T I F S : Elaborer des items de la stigmatisation vis-
a`-vis de la tuberculose (TB) et e´valuer leurs
modifications en re´ponse a` une intervention a` domicile
qui visait a` re´duire la transmission et la pre´valence de la
TB mais qui n’a pas e´te´ conc¸ue pour re´duire la
stigmatisation.
S C H E´MA : Stigmatisation vis-a`-vis de la TB a e´te´
mesure´e au de´part et 18 mois plus tard parmi 1826
patients TB re´cemment diagnostique´s et 1235 membres
adultes de leurs foyers dans 24 communaute´s ; 12 sur 24
communaute´s ont e´te´ tire´es au sort pour be´ne´ficier de
l’intervention a` domicile. Nous avons estime´ l’impact de
l’intervention a` domicile sur la stigmatisation TB graˆce a`
des me´thodes d’analyse de CRT standard.
R E´ S U LTAT S : Parmi les membres des foyers, la
pre´valence du blaˆme et des croyances relatives aux
mythes de transmission a chute´ dans les deux bras de
l’e´tude au fil du temps : les ratios de pre´valence ajuste´s
(aPR) comparant le bras intervention a` domicile avec le
bras non-intervention a` domicile ont e´te´ de 0,61 (IC95%
0,26–1,44) et de 0,77 (IC95% 0,48–1,25)
respectivement lors du suivi apre`s 18 mois. Parmi les
patients TB, au de´part, un faible pourcentage a
expe´rimente´ une exclusion sociale et un accueil
me´diocre par le personnel de sante´ ; un pourcentage
relativement e´leve´ a de´clare´ avoir e´te´ « moque´ », avec
peu d’e´volution dans le temps. La divulgation du statut
TB a augmente´ avec le temps dans les deux bras de
l’e´tude. La stigmatisation internalise´e a e´te´ moins
pre´valente dans le bras intervention a` domicile a` la fois
au de´part et lors du suivi, avec un aPR de 0,85 (IC95%
0,41–1,76). La variabilite´ des niveaux de stigmatisation
entre pays et a` travers les communaute´s a e´te´ importante.
CONC LU S I ON : Des items solides de stigmatisation TB
ont e´te´ e´labore´s. La stigmatisation TB n’a pas e´te´
significativement re´duite par l’intervention a` domicile,
bien que les intervalles de confiance des effets estime´s de
l’intervention aient e´te´ larges. Nous sugge´rons que des
interventions spe´cifiques de la stigmatisation sont
requises afin d’affronter efficacement la stigmatisation
vis-a`-vis de la TB.
R E S UM E N
MARCO DE R E F E R ENC I A: Las comunidades en Zambia
y Sura´frica que participaron en un ensayo clı´nico
aleatorizado por conglomerados (CRT), cuyo objetivo
era disminuir la TB y la infeccio´n por el VIH
(ZAMSTAR), realizado del 2006 al 2009.
OB J E T I VO S: Definir los elementos de la estigmatizacio´n
que se asocia con la tuberculosis (TB) y analizar en que´
medida se modificaron en respuesta a una intervencio´n
domiciliaria encaminada a disminuir la transmisio´n de la
TB y su prevalencia, pero que no se habı´a disen˜ado con
el objeto de reducir los estigmas.
M E´ TODO: Se midio´ la estigmatizacio´n relacionada con
la TB al comienzo del estudio y 18 meses ma´s tarde en
1826 pacientes con diagno´stico reciente de TB y 1235
adultos miembros de su familia en 24 comunidades; se
escogieron de manera aleatoria 12 de las 24
comunidades para participar en la intervencio´n
domiciliaria. Se estimo´ el efecto de la intervencio´n
sobre los estigmas por TB mediante me´todos corrientes
de ana´lisis de los ensayos aleatorizados.
R E SU LTADOS: La prevalencia de culpa y la creencia en
los mitos sobre la transmisio´n disminuyeron en ambos
grupos del estudio con el transcurso del tiempo, a saber:
despue´s de 18 meses de seguimiento la tasa de
prevalencia ajustada (aPR) en el grupo que participo´
en la intervencio´n fue 0,61 (IC95% 0,26–1,44)
comparada con 0,77 en el grupo que no participo´
(IC95% 0,48–1,25). Al comienzo del estudio, un bajo
porcentaje de los pacientes con TB percibı´a exclusio´n
social y un tratamiento inadecuado por parte del
personal de salud y un porcentaje relativamente alto
referı´a ‘sentirse burlado’; la modificacio´n fue mı´nima
con el transcurso del tiempo. La revelacio´n de la
situacio´n con respecto a la TB aumento´ con el tiempo
en ambos grupos del estudio. Los estigmas percibidos
fueron menos frecuentes en el grupo que participo´ en la
intervencio´n, al comienzo y tambie´n durante el
seguimiento, con una aPR de 0,85 (IC95% 0,41–1,76).
Se observo´ una amplia variabilidad en el grado de
estigmatizacio´n en los diferentes paı´ses y las diversas
comunidades.
CONC LU S I O´ N: Se formularon elementos so´lidos sobre
la estigmatizacio´n relacionada con la TB. La
intervencio´n en los hogares no disminuyo´ de manera
significativa los estigmas, pese a que los IC de los efectos
de la intervencio´n fueron amplios. Se propone que con el
fin de responder de manera eficaz a la estigmatizacio´n
generada por la TB es necesario disen˜ar intervenciones
que aborden de manera especı´fica los estigmas.
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